No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
The Past Five Years for TELA Bio (NASDAQ:TELA) Investors Has Not Been Profitable
TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference
JMP Securities Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $12
Piper Sandler Maintains TELA Bio(TELA.US) With Buy Rating, Cuts Target Price to $5